UK Competition Law Newsletter

February 13, 2019

Welcome to the latest edition of our UK Competition Law Newsletter – a monthly briefing on developments in UK antitrust law, enforcement, and practice.

Highlights include:

  • CAT quashes the CMA’s record antitrust fine in Pfizer/Flynn, finding that the CMA misapplied
    the legal test for excessive pricing.
  • CMA shines spotlight on digital platforms, conducting several Phase 2 reviews and considering
    further work in digital advertising.
  • UK competition regime prepares for Brexit, despite significant uncertainty about how, when, or
    if it will occur.

Please click here to read the newsletter.